Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Currently, there are many sales companies in the world Aprotinin industry, especially in India and China. The main market players are Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited and Guangdong Techpool Bio-pharma. The sale Revenue of Aprotinin is about 123458 K USD in 2015.
North America is the largest consumption region of Aprotinin, with a Revenue market share nearly 20.28% in 2015.
The second consumption place is Europe; ...
Table of Contents
2019-2024 Global Aprotinin Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aprotinin Consumption 2014-2024
2.1.2 Aprotinin Consumption CAGR by Region
2.2 Aprotinin Segment by Type
2.2.1 Aprotinin (From bovine lung)
2.2.2 Recombinant Aprotinin
2.3 Aprotinin Consumption by Type
2.3.1 Global Aprotinin Consumption Market Share by Type (2014-2019)
2.3.2 Global Aprotinin Revenue and Market Share by Type (2014-2019)
2.3.3 Global Aprotinin Sale Price by Type (2014-2019)
2.4 Aprotinin Segment by Application
2.4.2 Scientific Research & Experiment
2.5 Aprotinin Consumption by Application
2.5.1 Global Aprotinin Consumption Market ...